Select Agents | Global Biodefense

Menu

Funding for Preclinical Development of Countermeasures Against Select Pathogens

New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans

by Global Biodefense Staff April 16, 2020, 11:15 am
USAMRIID Resumes Full Operations Following Federal Select Agent Program Reinstatement

by Global Biodefense Staff April 1, 2020, 2:12 pm
Critical Bioeconomy Asset in Need of Attention: BSL-3 and BSL-4 Laboratories in the U.S.

by Global Biodefense Staff March 6, 2020, 3:02 pm
CCD Detector System for Abrin Toxin Activity

by Global Biodefense Staff March 6, 2020, 2:05 pm
Tandem Mass Spec for Select Agent Detection

by Global Biodefense Staff March 6, 2020, 2:03 pm
Passive Immunization with mAbs Against Aerosolized Ricin Toxin

by Global Biodefense Staff March 6, 2020, 2:03 pm
A Call to Action on Plague Research

by Global Biodefense Staff February 28, 2020, 8:02 pm
Belarus Man Indicted for Mailing Ricin and Threats to Pelican Bay State Prison

by Global Biodefense Staff February 27, 2020, 6:34 pm
U.S. Ebola Treatment Center Costs and Sustainability if Federal Funding Withdrawn

by Global Biodefense Staff February 25, 2020, 11:33 pm
FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning

by Global Biodefense Staff February 16, 2020, 6:53 pm
Antibody Mixture May Help Block Ebola Virus Infection

by Global Biodefense Staff February 6, 2020, 1:46 pm
Boston Hospital Only New England Center Designated to Treat Ebola Patients

by Global Biodefense Staff January 22, 2020, 10:08 pm
MSF Update on Ebola Frontline Response

by Global Biodefense Staff January 20, 2020, 1:22 pm
Scientists Create Decoy Molecule that Neutralizes Arenaviruses

by Global Biodefense Staff January 8, 2020, 10:30 pm

Congratulations. You've reached the end of the internet.

Back to Top

Close